PRPF31 and retinal degeneration: To test the use of AAV-mediated gene augmentation therapy for the treatment of PRPF31-associated retinal degeneration, Brydon and colleagues knocked out the PRPF31 gene using CRISPR/Cas9 genome editing in healthy iPSC.